{"content":"<li class=\"n-box-item date-title\" data-end=\"1460001599\" data-start=\"1459915200\" data-txt=\"Sunday, December 22, 2019\">Wednesday, April  6, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3171840\" data-ts=\"1459988908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOR\" target=\"_blank\">SHOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171840-shoretel-launches-cloud-based-voice-service-in-australia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ShoreTel launches its cloud-based voice service in Australia</a></h4><ul>   <li>Unified communications provider ShoreTel (<a href=\"https://seekingalpha.com/symbol/SHOR\" title=\"ShoreTel, Inc.\">SHOR</a> <font color=\"green\">+1.6%</font>) has launched a cloud-based voice service in Australia under its own brand.</li>    <li>The company offered what's now ShoreTel Hosted Voice under the brand of M5 Networks Australia, but has now fully integrated M5 and launched enhancements.</li>    <li>The service is a fully managed IP solution, with full features including voicemail, unified messaging, click to dial, mobility and audio conferencing services along with optional add-ons.</li>    <li>Along with the rollout, ShoreTel is opening a new office in Melbourne tomorrow. The cloud communications market will generate $650M in revenues in Australia by 2020, the company says.</li>    <li>Now read <a href=\"https://seekingalpha.com/article/3963446-intel-becomes-transparent-whatsapp-embraces-encryption-amazon-preps-new-kindle\" target=\"_blank\"><b>Intel Becomes More Transparent, WhatsApp Embraces Encryption, Amazon Preps A New Kindle »</b></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171840\" data-linked=\"ShoreTel launches its cloud-based voice service in Australia\" data-tweet=\"$SHOR - ShoreTel launches its cloud-based voice service in Australia https://seekingalpha.com/news/3171840-shoretel-launches-cloud-based-voice-service-in-australia?source=tweet\" data-url=\"https://seekingalpha.com/news/3171840-shoretel-launches-cloud-based-voice-service-in-australia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171838\" data-ts=\"1459986367\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOLTF\" target=\"_blank\">SOLTF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171838-allergan-partnering-heptares-to-target-neurological-disorders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allergan partnering with Heptares to target neurological disorders</a></h4><ul>   <li>Moving on from a <a href=\"https://seekingalpha.com/news/3171644-allergan-pfizer-merger-officially-pfizer-reimburse-allergan-150m-expenses\" target=\"_blank\">broken merger</a>, Allergan (<a href=\"https://seekingalpha.com/symbol/AGN\" title=\"Allergan plc\">AGN</a> <font color=\"green\">+3.6%</font>) says it's formed a global R&amp;D and commercialization partnership with Heptares Therapeutics (<a href=\"https://seekingalpha.com/symbol/SOLTF\" title=\"Sosei Co., Ltd.\">OTCPK:SOLTF</a>) to pursue novel treatments for neurological disorders.</li>    <li>Allergan will issue an up-front payment of $125M, and Heptares is eligible for milestone payments of up to $665M contingent on successful Phase 1, 2 and 3 development and launch of the first three licensed compounds for multiple indications, along with royalties and up to $2.5B tied to sales thresholds.</li>    <li>The two will work to develop and commercialize small molecule agonists targeting muscarinic receptors in the brain, to address Alzheimer's and related disorders.</li>    <li>Now read <a href=\"https://seekingalpha.com/article/3963457-allergan-pfizer-merger-now-dead-allergan\" target=\"_blank\"><b>The Allergan-Pfizer Merger Is Now Dead, But Allergan Isn't »</b></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171838\" data-linked=\"Allergan partnering with Heptares to target neurological disorders\" data-tweet=\"$SOLTF $SOLTF $AGN - Allergan partnering with Heptares to target neurological disorders https://seekingalpha.com/news/3171838-allergan-partnering-heptares-to-target-neurological-disorders?source=tweet\" data-url=\"https://seekingalpha.com/news/3171838-allergan-partnering-heptares-to-target-neurological-disorders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171835\" data-ts=\"1459983432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEQP\" target=\"_blank\">CEQP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171835-crestwood-wins-10-year-gas-gathering-contract-in-barnett-shale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crestwood wins 10-year gas gathering contract in Barnett Shale</a></h4><ul>     <li>Crestwood Equity Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/CEQP\" title=\"Crestwood Equity Partners LP\">CEQP</a>) <font color=\"green\">+9.8%</font> AH after announcing a 10-year contract to gather and process gas from Bluestone Natural Resources II's Barnett Shale  operations in Texas.</li>     <li>Financial terms are not disclosed, but CEQP will provide services under a fixed-fee and percent of proceeds fee structure.</li>     <li>In connection with BlueStone's closing of the acquisition of Quicksilver Resources' Barnett Shale assets, Quicksilver withdrew its motion to reject CEQP\u2019s legacy gathering agreements relating to its Barnett Shale assets.</li>     <li>Now read <a href=\"https://seekingalpha.com/article/3961798-mlp-bottom-fishing-4-crestwood-equity-partners\" target=\"_blank\"><strong>MLP bottom fishing 4: Crestwood Energy Partners</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171835\" data-linked=\"Crestwood wins 10-year gas gathering contract in Barnett Shale\" data-tweet=\"$CEQP - Crestwood wins 10-year gas gathering contract in Barnett Shale https://seekingalpha.com/news/3171835-crestwood-wins-10-year-gas-gathering-contract-in-barnett-shale?source=tweet\" data-url=\"https://seekingalpha.com/news/3171835-crestwood-wins-10-year-gas-gathering-contract-in-barnett-shale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171828\" data-ts=\"1459978879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171828-reports-valeant-wins-majority-lender-support-for-default-waiver\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reports: Valeant wins majority lender support for default waiver</a></h4><ul>     <li>Valeant Pharmaceuticals (VRX) <font color=\"green\">+3.7%</font> AH after winning a <a href=\"http://www.bloomberg.com/news/articles/2016-04-06/valeant-said-to-win-majority-lender-support-for-default-waiver\" target=\"_blank\">commitment from a majority of its lenders to waive a default</a> and ease  some restrictions on its loan pact, giving it some  breathing room to rein in its $32B debt load, according to multiple reports; the company needed approval from more than half of the holders of its $11B-plus of secured loans.</li>\n<li>VRX <a href=\"http://www.wsj.com/articles/valeant-gets-loan-holders-agree-to-amend-terms-of-debt-1459974667\" target=\"_blank\">agrees to pay</a> a fee of $50K per $10M of loans to  lenders for the amendment and to boost interest rates on the debt by one  percentage point, though the rate could decline if it achieves  certain financial metrics, <em>WSJ</em> reports.</li>\n<li>In regular trading, VRX stock enjoyed its <a href=\"http://www.marketwatch.com/story/valeants-stock-rockets-to-best-two-day-gain-in-20-years-2016-04-06\" target=\"_blank\">best two-day  gain in 20 years</a>, after bullish comments from Bill Ackman came on the heels of a <a href=\"https://seekingalpha.com/news/3171470-valeant-ad-hoc-committee-investigation-additional-restatements-required-shares-13-percent\" target=\"_blank\">resolution of some accounting issues</a>; shares soared 19% today after climbing 10% yesterday.</li>\n<li>Ackman said in Pershing Square's quarterly conference call that VRX stock has  a \u201cremarkably low valuation for a business of this quality.\u201d</li>\n<li>Now read <a href=\"https://seekingalpha.com/article/3963512-want-stay-long-valeant\" target=\"_blank\"><strong>So you want to stay long Valeant?</strong></a>\n</li>\n<li>\n<strong>Update</strong>: The company obtained lender approval for the amendment and waiver to its credit facility on April 7. It expects to close within a week.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171828\" data-linked=\"Reports: Valeant wins majority lender support for default waiver\" data-tweet=\"$BHC - Reports: Valeant wins majority lender support for default waiver https://seekingalpha.com/news/3171828-reports-valeant-wins-majority-lender-support-for-default-waiver?source=tweet\" data-url=\"https://seekingalpha.com/news/3171828-reports-valeant-wins-majority-lender-support-for-default-waiver\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>81&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171827\" data-ts=\"1459978616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171827-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top gainers, as of 5.25 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/APOG\" title=\"Apogee Enterprises, Inc.\">APOG</a> <font color=\"green\">+5.0%</font>. <a href=\"https://seekingalpha.com/symbol/OLLI\" title=\"Ollie's Bargain Outlet Holdings\">OLLI</a> <font color=\"green\">+5.3%</font>. VRX <font color=\"green\">+3.7%</font>. <a href=\"https://seekingalpha.com/symbol/TEX\" title=\"Terex Corporation\">TEX</a> <font color=\"green\">+3.6%</font>. <a href=\"https://seekingalpha.com/symbol/BBBY\" title=\"Bed Bath &amp; Beyond Inc.\">BBBY</a> <font color=\"green\">+3.4%</font>.</li>\n<li>\n<b>Top losers, as of 5.25p.m.:</b> <a href=\"https://seekingalpha.com/symbol/TSQ\" title=\"Townsquare Media\">TSQ</a> <font color=\"red\">-9.1%</font>. <a href=\"https://seekingalpha.com/symbol/BBL\" title=\"BHP Billiton plc\">BBL</a> <font color=\"red\">-4.7%</font>. <a href=\"https://seekingalpha.com/symbol/RPTP\" title=\"Raptor Pharmaceutical Corp.\">RPTP</a> <font color=\"red\">-4.5%</font>. <a href=\"https://seekingalpha.com/symbol/ALDR\" title=\"Alder Biopharmaceuticals Inc.\">ALDR</a> <font color=\"red\">-4.0%</font>. <a href=\"https://seekingalpha.com/symbol/CLLS\" title=\"Cellectis S.A.\">CLLS</a> <font color=\"red\">-3.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171827\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$APOG $OLLI $BHC - After Hours Gainers / Losers https://seekingalpha.com/news/3171827-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3171827-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171816\" data-ts=\"1459974897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APOG\" target=\"_blank\">APOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171816-apogee-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apogee beats by $0.05, beats on revenue</a></h4><ul>\n<li>Apogee (NASDAQ:<a href=\"https://seekingalpha.com/symbol/APOG\" title=\"Apogee Enterprises, Inc.\">APOG</a>): Q4 EPS of $0.69 <font color=\"green\">beats by $0.05</font>.</li>\n<li>Revenue of $262.1M (+6.2% Y/Y) <font color=\"green\">beats by $2.95M</font>.</li>\n<li>Shares <font color=\"green\">+1.75%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171816\" data-linked=\"Apogee beats by $0.05, beats on revenue\" data-tweet=\"$APOG - Apogee beats by $0.05, beats on revenue https://seekingalpha.com/news/3171816-apogee-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3171816-apogee-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171811\" data-ts=\"1459974490\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALDR\" target=\"_blank\">ALDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171811-alder-bio-commences-100m-equity-offering-shares-off-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alder Bio commences $100M equity offering; shares off 5% after hours</a></h4><ul>\n<li>Alder BioPharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ALDR\" title=\"Alder Biopharmaceuticals Inc.\">ALDR</a>) initiates a $100M public offering of common stock. Underwriters over-allotment will be an additional $15M of shares. Price, volume and terms have yet to be announced.</li>\n<li>Shares are down <font color=\"red\">5%</font> after hours on increased volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171811\" data-linked=\"Alder Bio commences $100M equity offering; shares off 5% after hours\" data-tweet=\"$ALDR - Alder Bio commences $100M equity offering; shares off 5% after hours https://seekingalpha.com/news/3171811-alder-bio-commences-100m-equity-offering-shares-off-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3171811-alder-bio-commences-100m-equity-offering-shares-off-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171808\" data-ts=\"1459973880\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171808-bed-bath-and-amp-beyond-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp;amp; Beyond  beats by $0.04, beats on revenue</a></h4><ul>\n<li>Bed Bath &amp; Beyond  (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BBBY\" title=\"Bed Bath &amp; Beyond Inc.\">BBBY</a>): FQ4 EPS of $1.85 <font color=\"green\">beats by $0.04</font>.</li>\n<li>Revenue of $3.42B (+2.4% Y/Y) <font color=\"green\">beats by $30M</font>.</li>\n<li>Shares <font color=\"green\">+5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171808\" data-linked=\"Bed Bath &amp;amp; Beyond  beats by $0.04, beats on revenue\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond beats by $0.04, beats on revenue https://seekingalpha.com/news/3171808-bed-bath-and-amp-beyond-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3171808-bed-bath-and-amp-beyond-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171797\" data-ts=\"1459972628\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WRES\" target=\"_blank\">WRES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171797-warren-resources-cautions-on-potential-bankruptcy-proceeding\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Warren Resources cautions on potential bankruptcy proceeding</a></h4><ul>     <li>Warren Resources (<a href=\"https://seekingalpha.com/symbol/WRES\" title=\"Warren Resources, Inc.\">WRES</a> <font color=\"red\">-6%</font>) is lower after saying it continues to engage in discussions with lenders and an ad hoc group of unsecured noteholders about a restructuring of its debt obligations, and is evaluating potential strategies including bankruptcy.</li>     <li>WRES says its first lien lender made an acceptable proposal for a post-restructuring capital structure that would result in deleveraging by converting a substantial amount of the company's debt to equity; however, agreement on a proposal among all three categories of creditors has not been reached.</li>     <li>WRES also names James Watt as chief restructuring officer, in addition to his other positions as  President and CEO.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171797\" data-linked=\"Warren Resources cautions on potential bankruptcy proceeding\" data-tweet=\"$WRES - Warren Resources cautions on potential bankruptcy proceeding https://seekingalpha.com/news/3171797-warren-resources-cautions-on-potential-bankruptcy-proceeding?source=tweet\" data-url=\"https://seekingalpha.com/news/3171797-warren-resources-cautions-on-potential-bankruptcy-proceeding\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171795\" data-ts=\"1459971562\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEGFQ\" target=\"_blank\">PEGFQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171795-bloomberg-pacific-e-and-p-co-chairmen-near-takeover-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Pacific E&amp;P co-chairmen near takeover deal</a></h4><ul>     <li>Pacific Exploration &amp; Production (PEGFF <font color=\"green\">+3.4%</font>) co-chairmen Serafino Iacono and Miguel de la Campa are <a href=\"http://www.bloomberg.com/news/articles/2016-04-06/pacific-said-nearing-agreement-to-take-over-bogota-oil-producer\" target=\"_blank\">close to clinching a deal</a> to take over the company after outbidding rivals, Bloomberg reports.</li>     <li>A bid by the co-chairmen is backed by Canadian P-E firm  Catalyst Capital Group, which is expected to provide ~$500M in funds secured against the company\u2019s assets, according to the report.</li>\n<li>Pacific failed to make bond interest payments in January and March, and  has struggled after deals in recent years ballooned its  debt before oil prices plunged.</li>\n<li>Now read <a href=\"https://seekingalpha.com/news/3169200-bloomberg-pacific-e-and-p-shareholders-lose-chairmens-bid\" target=\"_blank\"><strong>Bloomberg: Pacifc E&amp;P shareholders would lose all under chairmen's bid</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171795\" data-linked=\"Bloomberg: Pacific E&amp;P co-chairmen near takeover deal\" data-tweet=\"$PEGFQ - Bloomberg: Pacific E&amp;P co-chairmen near takeover deal https://seekingalpha.com/news/3171795-bloomberg-pacific-e-and-p-co-chairmen-near-takeover-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3171795-bloomberg-pacific-e-and-p-co-chairmen-near-takeover-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171787\" data-ts=\"1459969685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHPG\" target=\"_blank\">SHPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171787-baxalta-jumps-higher-shire-says-takeover-still-go\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baxalta jumps higher as Shire says takeover still a go</a></h4><ul><li>Shire (<a href=\"https://seekingalpha.com/symbol/SHPG\" title=\"Shire PLC\">SHPG</a> <font color=\"green\">+4.5%</font>) expects the deal with Baxalta (BXLT <font color=\"green\">+6.5%</font>) will proceed as originally announced on Jan. 11. As before, the merger is expected to close by mid-2016.</li></ul><div class=\"tiny-share-widget\" data-id=\"3171787\" data-linked=\"Baxalta jumps higher as Shire says takeover still a go\" data-tweet=\"$SHPG - Baxalta jumps higher as Shire says takeover still a go https://seekingalpha.com/news/3171787-baxalta-jumps-higher-shire-says-takeover-still-go?source=tweet\" data-url=\"https://seekingalpha.com/news/3171787-baxalta-jumps-higher-shire-says-takeover-still-go\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171782\" data-ts=\"1459968368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APC\" target=\"_blank\">APC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171782-stifel-downgrades-riskier-oil-stocks-ahead-of-opec-meeting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel downgrades &quot;riskier&quot; oil stocks ahead of OPEC meeting</a></h4><ul>     <li>Stifel analysts <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/04/06/run-away-stifel-cuts-oil-stocks-ahead-of-opec-meeting/\" target=\"_blank\">downgrade</a> Anadarko Petroleum (<a href=\"https://seekingalpha.com/symbol/APC\" title=\"Anadarko Petroleum Corporation\">APC</a> <font color=\"green\">+2.9%</font>), Continental Resources (<a href=\"https://seekingalpha.com/symbol/CLR\" title=\"Continental Resources, Inc.\">CLR</a> <font color=\"green\">+2.5%</font>), EOG Resources (<a href=\"https://seekingalpha.com/symbol/EOG\" title=\"EOG Resources, Inc.\">EOG</a> <font color=\"green\">+0.2%</font>), Matador Resources (<a href=\"https://seekingalpha.com/symbol/MTDR\" title=\"Matador Resources\">MTDR</a> <font color=\"green\">+4.1%</font>) and SM Energy (<a href=\"https://seekingalpha.com/symbol/SM\" title=\"SM Energy Company\">SM</a> <font color=\"green\">+5.1%</font>) to Hold from Buy, saying the stocks are too risky ahead of OPEC's April 17 meeting.</li>     <li>The firm says mixed signals from OPEC ministers, ramping volumes from Iran, and potential backlash from Saudi Arabia heightens oil price risk, causing it to become more defensive with its energy recommendations.</li>     <li>Stifel believes the five stocks are either underhedged on their production or outspending current 2016 cash flow.</li>     <li>Now read <a href=\"https://seekingalpha.com/news/3169721-merrill-lynch-oil-bottom\" target=\"_blank\"><strong>Merrill Lynch on Oil: The bottom is in</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171782\" data-linked=\"Stifel downgrades &quot;riskier&quot; oil stocks ahead of OPEC meeting\" data-tweet=\"$APC $APC $CLR - Stifel downgrades &quot;riskier&quot; oil stocks ahead of OPEC meeting https://seekingalpha.com/news/3171782-stifel-downgrades-riskier-oil-stocks-ahead-of-opec-meeting?source=tweet\" data-url=\"https://seekingalpha.com/news/3171782-stifel-downgrades-riskier-oil-stocks-ahead-of-opec-meeting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171779\" data-ts=\"1459966988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHGE\" target=\"_blank\">BHGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171779-baker-hughes-buy-halliburton-deal-folds-wells-fargo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baker Hughes a Buy if Halliburton deal folds, Wells Fargo says</a></h4><ul>     <li>Even while the target company traditionally fares worse than the acquirer when a merger deal dies, Wells Fargo <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/04/06/halliburton-baker-hughes-no-way-doj/\" target=\"_blank\">remains bullish</a> on Baker Hughes (BHI <font color=\"green\">+8%</font>), seeing \"an exceptionally strong balance sheet and operational upside potential off of a depressed base.\"</li>     <li>While acknowledging the risk with a suddenly stand-alone BHI in the state of the company\u2019s operational capabilities after a wave of departures, Fargo sees some positives for BHI that it says are going overlooked, most notably the strong balance sheet, with ~$5B in cash after a $3.5B breakup fee and BHI's significant cost cutting capacity to improve margins.</li>     <li>Citi analyst Scott Gruber estimates BHI would have $5B-plus of cash vs. $4B of debt if the deal breaks apart by Q3, which <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/04/7809778/dont-forget-baker-hughes-will-have-5-billion-in-cash-by-\" target=\"_blank\">could prompt a large stock buyback</a>; an enriched BHI also <a href=\"http://www.wsj.com/articles/halliburton-baker-hughes-deal-time-and-justice-take-a-toll-1459885667\" target=\"_blank\">could go shopping</a> for a lower tier competitor at a fat discount thanks to depressed oil and stock prices.</li>     <li>Bloomberg's Liam Denning notes that factoring in the breakup fee <a href=\"http://www.bloomberg.com/gadfly/articles/2016-04-06/baker-hughes-would-survive-halliburton-deal-breakup\" target=\"_blank\">pushes BHI's pro forma EBITDA multiple down</a> to ~9x from 10.8x 2017 EBITDA without the adjustment.</li>\n<li>Now read <a href=\"https://seekingalpha.com/news/3171726-baker-hughes-downgraded-deutsche-bank-deal-close-coin-flip-best\" target=\"_blank\"><strong>Baker Hughes downgraded at Deutsche Bank, as deal close \"a coin flip at best\"</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171779\" data-linked=\"Baker Hughes a Buy if Halliburton deal folds, Wells Fargo says\" data-tweet=\"$BHGE $BKR - Baker Hughes a Buy if Halliburton deal folds, Wells Fargo says https://seekingalpha.com/news/3171779-baker-hughes-buy-halliburton-deal-folds-wells-fargo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3171779-baker-hughes-buy-halliburton-deal-folds-wells-fargo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171778\" data-ts=\"1459966414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIBB\" target=\"_blank\">HIBB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171778-hibbett-sports-in-retreat-after-bofa-loses-faith\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hibbett Sports in retreat after BofA loses faith</a></h4><ul><li>Shares of Hibbett Sports (<a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a> <font color='red'>-5.1%</font>) crumble after Bank of America Merrill Lynch downgrades the retailer to a Sell rating from Neutral.</li><li>Hibbett has stuck with a plan to expand, despite slumping comps and margin rates.</li><li>Now read&nbsp;<a href=\"https://seekingalpha.com/article/3958075-hibbett-sports-upside-captured\" target=\"_blank\"><strong>Hibbett Sports: Upside Has Been Captured</strong></a><strong>&nbsp;</strong></li></ul><div class=\"tiny-share-widget\" data-id=\"3171778\" data-linked=\"Hibbett Sports in retreat after BofA loses faith\" data-tweet=\"$HIBB - Hibbett Sports in retreat after BofA loses faith https://seekingalpha.com/news/3171778-hibbett-sports-in-retreat-after-bofa-loses-faith?source=tweet\" data-url=\"https://seekingalpha.com/news/3171778-hibbett-sports-in-retreat-after-bofa-loses-faith\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171773\" data-ts=\"1459964753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171773-gilead-takeout-of-nimbus-stokes-buying-in-nash-players\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead takeout of Nimbus stokes buying in other NASH players</a></h4><ul>\n<li>Gilead Sciences' (<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a> <font color=\"green\">+2%</font>) acquisition of Nimbus Therapeutics for as much as $1.2B appears to have investors in a lather over other developers of therapies to treat nonalcoholic steatohepatitis (NASH), especially Galmed Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/GLMD\" title=\"Galmed Pharmaceuticals Ltd.\">GLMD</a> <font color=\"green\">+38.3%</font>).</li>\n<li>NASH-related tickers: (<a href=\"https://seekingalpha.com/symbol/MNOV\" title=\"MediciNova, Inc.\">MNOV</a> <font color=\"green\">+0.4%</font>)(<a href=\"https://seekingalpha.com/symbol/RGLS\" title=\"Regulus Therapeutics\">RGLS</a> <font color=\"green\">+4.8%</font>)(<a href=\"https://seekingalpha.com/symbol/ICPT\" title=\"Intercept Pharmaceuticals\">ICPT</a> <font color=\"green\">+4.4%</font>)(<a href=\"https://seekingalpha.com/symbol/CNAT\" title=\"Conatus Pharmaceuticals\">CNAT</a> <font color=\"green\">+10.9%</font>)(<a href=\"https://seekingalpha.com/symbol/VBLT\" title=\"VBL Therapeutics\">VBLT</a> <font color=\"green\">+3%</font>)(<a href=\"https://seekingalpha.com/symbol/GALT\" title=\"Galectin Therapeutics, Inc.\">GALT</a> <font color=\"green\">+2%</font>)(<a href=\"https://seekingalpha.com/symbol/TBRA\" title=\"Tobira Therapeutics, Inc.\">TBRA</a> <font color=\"red\">-0.1%</font>)(<a href=\"https://seekingalpha.com/symbol/ISLT\" title=\"Islet Sciences, Inc.\">OTC:ISLT</a>)(<a href=\"https://seekingalpha.com/symbol/SHPG\" title=\"Shire PLC\">SHPG</a> <font color=\"green\">+7.2%</font>)(<a href=\"https://seekingalpha.com/symbol/RPTP\" title=\"Raptor Pharmaceutical Corp.\">RPTP</a> <font color=\"green\">+3.6%</font>)(<a href=\"https://seekingalpha.com/symbol/GNFTF\" title=\"Genfit\">OTCPK:GNFTF</a> <font color=\"red\">-0.9%</font>)(<a href=\"https://seekingalpha.com/symbol/CANF\" title=\"Can-Fite Biopharma Ltd\">CANF</a> <font color=\"green\">+11.8%</font>)</li>\n<li>Read now <a href=\"https://seekingalpha.com/article/3963505-nash-drugs-comprehensive-review-current-clinical-trials\" target=\"_blank\">NASH Drugs: A Comprehensive Review Of Current Clinical Trials</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171773\" data-linked=\"Gilead takeout of Nimbus stokes buying in other NASH players\" data-tweet=\"$GILD $GILD $GLMD - Gilead takeout of Nimbus stokes buying in other NASH players https://seekingalpha.com/news/3171773-gilead-takeout-of-nimbus-stokes-buying-in-nash-players?source=tweet\" data-url=\"https://seekingalpha.com/news/3171773-gilead-takeout-of-nimbus-stokes-buying-in-nash-players\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171764\" data-ts=\"1459961936\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171764-all-time-high-for-constellation-brands-off-of-healthy-mix-of-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">All-time high for Constellation Brands off of healthy mix of news</a></h4><ul>     <li>Constellation Brands (<a href=\"https://seekingalpha.com/symbol/STZ\" title=\"Constellation Brands, Inc.\">STZ</a> <font color=\"green\">+5%</font>) announces it acquired wine brands from The Prisoner Company for about $285M. The addition is expected to add $0.03 to $0.05 to earnings per share this year.</li>     <li>An IPO for a part of Constellation's Canadian wine business is also potentially in the works.</li> <li>The company didn't forget about paying shareholders. The Class A stock quarterly dividend goes to $0.40/share and the Class B payout will be $0.36/share.</li>\n<li>Shares of Constellation Brands reached an all-time high of $159.33.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3171667-constellation-brands-updates-fy17-guidance\" target=\"_blank\">Constellation Brands updates FY17 guidance</a> (April 6)</li>\n<li>Now Read <a href=\"https://seekingalpha.com/article/3960321-b-constellation-b-brands-stz-q4-2016-results-earnings-call-webcast\" target=\"_blank\"><strong>Constellation Brands Q4 earnings call transcript</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171764\" data-linked=\"All-time high for Constellation Brands off of healthy mix of news\" data-tweet=\"$STZ - All-time high for Constellation Brands off of healthy mix of news https://seekingalpha.com/news/3171764-all-time-high-for-constellation-brands-off-of-healthy-mix-of-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3171764-all-time-high-for-constellation-brands-off-of-healthy-mix-of-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171762\" data-ts=\"1459961203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171762-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers/ Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MOMO' title='Momo'>MOMO</a> <font color='green'>+32%</font>. TKAI <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/BSI' title='Blue Square-Israel Ltd ADR'>BSI</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/CWEI' title='Clayton Williams Energy, Inc.'>CWEI</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/VSR' title='Versar, Inc'>VSR</a> <font color='green'>+17%</font>. CJES <font color='green'>+17%</font>. VRX <font color='green'>+17%</font>. SYMX <font color='green'>+16%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/BIND' title='BIND Therapeutics, Inc.'>BIND</a> <font color='red'>-29%</font>. FHCO <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/SKYS' title='Sky Solar Holdings'>SKYS</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/AEL' title='American Equity Investment Life Holding Company'>AEL</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/JCAP' title='Jernigan Capital'>JCAP</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/CREE' title='Cree, Inc.'>CREE</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/INVT' title='Inventergy Global, Inc.'>OTC:INVT</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CDRB' title='Code Rebel Corp'>CDRB</a> <font color='red'>-10%</font>. ROIAK <font color='red'>-11%&nbsp;</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3171762\" data-linked=\"Midday Gainers/ Losers\" data-tweet=\"$MOMO $NVUS $GLMD - Midday Gainers/ Losers https://seekingalpha.com/news/3171762-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3171762-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171759\" data-ts=\"1459960877\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OI\" target=\"_blank\">OI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171759-owens-illinois-upgraded-to-buy-citi-which-says-inflection-point-coming\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Owens-Illinois upgraded to Buy at Citi, which says inflection point coming</a></h4><ul>     <li>Owens-Illinois (<a href=\"https://seekingalpha.com/symbol/OI\" title=\"Owens-Illinois, Inc.\">OI</a> <font color=\"green\">+5.6%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/04/7809804/citi-boosts-owens-illinois-to-buy-earnings-inflection-po\" target=\"_blank\">upgraded to Buy</a> from Neutral with a $19 price target, hiked from $15, at Citigroup, which says 2016 should serve as an earnings inflection point.</li>     <li>Citi expects OI to generate EPS growth of 11% during 2016-18, backed by the company stabilizing pricing, reaping volume benefits from recently renegotiated contracts, improving its operations and paying down debt.</li>     <li>The firm believes OI management has set \"beatable targets\u201d for earnings, and expects reiteration of FY 2016 guidance when the company reports May 2 to be a catalyst for the stock.</li>     <li>Investor sentiment in OI has suffered as shares have plunged ~35% over the past year, with the company issuing three consecutive guidance cuts.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171759\" data-linked=\"Owens-Illinois upgraded to Buy at Citi, which says inflection point coming\" data-tweet=\"$OI - Owens-Illinois upgraded to Buy at Citi, which says inflection point coming https://seekingalpha.com/news/3171759-owens-illinois-upgraded-to-buy-citi-which-says-inflection-point-coming?source=tweet\" data-url=\"https://seekingalpha.com/news/3171759-owens-illinois-upgraded-to-buy-citi-which-says-inflection-point-coming\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171748\" data-ts=\"1459958875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVUS\" target=\"_blank\">NVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171748-tokai-pharma-sees-buying-on-bullish-ratings-shares-up-23\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tokai Pharma sees buying on bullish ratings; shares up 23%</a></h4><ul>\n<li>Thinly traded micro cap Tokai Pharmaceuticals (TKAI <font color=\"green\">+22.7%</font>) is up on a 5x surge in volume, albeit on turnover of only ~300K shares, in apparent response to the initiation of coverage by Bank of America with a Buy rating and $16 (126% upside) price target.</li>\n<li>Oppenheimer rates it Outperform with a $38 (437% upside) price target.</li>\n<li>Boston, MA-based Tokai's lead product candidate is <a href=\"http://www.tokaipharma.com/programs.php\" target=\"_blank\">Galeterone</a>, an orally available small molecule that disrupts the androgen receptor (AR) signaling pathway by degrading AR, blocking the binding of testosterone or dihydrotestosterone with AR and inhibiting <a href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047603/\" target=\"_blank\">CYP17</a>, an enzyme that plays a key role in the synthesis of testosterone. Prostate cancer is stoked by androgens acting through the androgen receptor. It is currently in Phase 3 development. Some analysts believe it will outperform Medivation's (<a href=\"https://seekingalpha.com/symbol/MDVN\" title=\"Medivation, Inc.\">MDVN</a> <font color=\"green\">+4.4%</font>) <a href=\"http://www.medivation.com/research_development/enzalutamide\" target=\"_blank\">enzalutamide</a>, also an androgen receptor inhibitor.</li>\n<li>Read now <a href=\"https://seekingalpha.com/article/3632506-wrong-tokai-pharmaceuticals\" target=\"_blank\">What's Wrong With Tokai Pharmaceuticals?</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171748\" data-linked=\"Tokai Pharma sees buying on bullish ratings; shares up 23%\" data-tweet=\"$NVUS $NVUS $MDVN - Tokai Pharma sees buying on bullish ratings; shares up 23% https://seekingalpha.com/news/3171748-tokai-pharma-sees-buying-on-bullish-ratings-shares-up-23?source=tweet\" data-url=\"https://seekingalpha.com/news/3171748-tokai-pharma-sees-buying-on-bullish-ratings-shares-up-23\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171747\" data-ts=\"1459958251\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPX\" target=\"_blank\">WPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171747-wpx-energy-started-buy-wunderlich\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WPX Energy started at Buy at Wunderlich</a></h4><ul>     <li>WPX Energy (<a href=\"https://seekingalpha.com/symbol/WPX\" title=\"WPX Energy, Inc.\">WPX</a> <font color=\"green\">+9.8%</font>) is initiated with a <a href=\"http://www.streetinsider.com/New+Coverage/Wunderlich+Securities+Starts+WPX+Energy+%28WPX%29+at+Buy/11479609.html\" target=\"_blank\">Buy rating</a> and $11 price target at Wunderlich, which believes the company has the right portfolio and team to succeed.</li>     <li>WPX began trading in 2012 as a spinoff from Williams Cos. and inherited a very gassy portfolio, and new management was brought in to remake WPX and simplify the geographic focus; WPX has completed or announced $2.75B of acquisitions  and $2.7B of divestitures in the last two years, paring down to just three basins - the Permian, Williston and San Juan.</li>     <li>Wunderlich sees a good entry point to buy WPX shares, which it thinks are undervalued as Wall Street is skeptical of the company's ability to close the Piceance sale.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171747\" data-linked=\"WPX Energy started at Buy at Wunderlich\" data-tweet=\"$WPX - WPX Energy started at Buy at Wunderlich https://seekingalpha.com/news/3171747-wpx-energy-started-buy-wunderlich?source=tweet\" data-url=\"https://seekingalpha.com/news/3171747-wpx-energy-started-buy-wunderlich\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171745\" data-ts=\"1459957770\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171745-us-steel-to-lay-off-25-of-salaried-workers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">US. Steel to lay off 25% of salaried workers</a></h4><ul>     <li>U.S. Steel (<a href=\"https://seekingalpha.com/symbol/X\" title=\"United States Steel Corporation\">X</a> <font color=\"green\">+3.2%</font>) reportedly is <a href=\"http://triblive.com/business/headlines/10263460-74/steel-workers-salaried\" target=\"_blank\">laying off ~25% of its salaried workforce in North America</a>, and is restructuring its European operations, as it cuts costs to deal with weak demand and low metal prices.</li>     <li>U.S. Steel says it is making cuts but is not providing a specific number of workers who will lose their jobs; <a href=\"https://seekingalpha.com/news/3168530-u-s-steel-lays-800-alabama-ohio-texas\" target=\"_blank\">last month</a>, the company said it was cutting ~800 hourly and salaried workers from its tubular operations in three states in response to the slumping energy industry.</li>     <li>The company had 21K workers in North America at year-end 2015, including ~3K non-union workers, meaning that layoffs of 25% of the salaried workforce could affect 750 employees; it employs 12K in Europe, primarily at a steel mill in Slovakia.</li>\n<li>Now read <a href=\"https://seekingalpha.com/news/3170061-u-s-steel-ebitda-outlook-raised-rosenblatt-flat-rolled-pricing-strength\" target=\"_blank\"><strong>U.S. Steel EBITDA outlook raised at Rosenblatt on flat rolled pricing strength</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171745\" data-linked=\"US. Steel to lay off 25% of salaried workers\" data-tweet=\"$X - US. Steel to lay off 25% of salaried workers https://seekingalpha.com/news/3171745-us-steel-to-lay-off-25-of-salaried-workers?source=tweet\" data-url=\"https://seekingalpha.com/news/3171745-us-steel-to-lay-off-25-of-salaried-workers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171740\" data-ts=\"1459957127\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCHN\" target=\"_blank\">SCHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171740-schnitzer-steelminus-4-on-fq2-results-sales-prices-fell-to-multi-year-lows\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schnitzer Steel -4% on FQ2 results as sales prices fell to multi-year lows</a></h4><ul>     <li>Schnitzer Steel (<a href=\"https://seekingalpha.com/symbol/SCHN\" title=\"Schnitzer Steel Industries, Inc.\">SCHN</a> <font color=\"red\">-4.1%</font>) is sharply lower after reporting a slightly <a href=\"https://seekingalpha.com/news/3171660-schnitzer-steel-beats-0_01-misses-revenue\" target=\"_blank\">less than expected FQ2 loss</a> but a worse than expected 34% drop in revenues, as the operating loss in its auto and metals recycling business was trimmed to $26M from $189 in the year-ago period, but weak metal prices and weak export demand <a href=\"http://www.marketwatch.com/story/schnitzer-steel-sales-fall-sees-volatility-ahead-2016-04-06\" target=\"_blank\">continue to weigh results</a>.</li>     <li>SCHN says it expects its steel manufacturing business to deliver positive results, as sales are expected to increase amid further cost reduction efforts, and sees stronger results in its auto and metals recycling business.</li>\n<li>SCHN says cost cuts would  contribute to expanded margins and better financial performance as market conditions improve.</li>     <li>Now read (from Mar. 28) <a href=\"https://seekingalpha.com/news/3169859-schnitzer-steel-issues-downside-q2-earnings-guidance-q2\" target=\"_blank\"><strong>Schnitzer Steel issues downside Q2 earnings guidance</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171740\" data-linked=\"Schnitzer Steel -4% on FQ2 results as sales prices fell to multi-year lows\" data-tweet=\"$SCHN - Schnitzer Steel -4% on FQ2 results as sales prices fell to multi-year lows https://seekingalpha.com/news/3171740-schnitzer-steelminus-4-on-fq2-results-sales-prices-fell-to-multi-year-lows?source=tweet\" data-url=\"https://seekingalpha.com/news/3171740-schnitzer-steelminus-4-on-fq2-results-sales-prices-fell-to-multi-year-lows\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171738\" data-ts=\"1459955825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNC\" target=\"_blank\">GNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171738-gnc-holdings-in-rally-mode-after-report-on-traffic-looks-favorable\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GNC Holdings in rally mode after report on traffic looks favorable</a></h4><ul> <li>GNC Holdings (NYSE:<a href='https://seekingalpha.com/symbol/GNC' title='GNC Holdings, Inc.'>GNC</a>) is&nbsp;<font color='green'>up 4.4%</font>&nbsp;after data from <a href=\"http://www.itg.com/\" target=\"_blank\">ITG</a> suggests traffic trends are stronger than expected. Shares are only pennies away from reaching the $32 level for the first time since early January.</li> <li>The company isn't due to report Q1 earnings until early May.</li><li>Now read&nbsp;<a href=\"https://seekingalpha.com/article/3916986-b-gnc-b-holdings-terrific-capital-return-story\" target=\"_blank\"><strong>GNC Holdings Is A Terrific Capital Return Story</strong></a><strong>&nbsp;</strong></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3171738\" data-linked=\"GNC Holdings in rally mode after report on traffic looks favorable\" data-tweet=\"$GNC - GNC Holdings in rally mode after report on traffic looks favorable https://seekingalpha.com/news/3171738-gnc-holdings-in-rally-mode-after-report-on-traffic-looks-favorable?source=tweet\" data-url=\"https://seekingalpha.com/news/3171738-gnc-holdings-in-rally-mode-after-report-on-traffic-looks-favorable\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171727\" data-ts=\"1459953908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JOY\" target=\"_blank\">JOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171727-goldman-reaffirms-sell-rating-on-joy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman reaffirms Sell rating on Joy</a></h4><ul><li>Joy Global (<a href='https://seekingalpha.com/symbol/JOY' title='Joy Global Inc.'>JOY</a> <font color='red'>-4.2%</font>) falls into the red in early trade after Goldman Sachs <a href=\"http://www.sfhfm.org/goldman-sachs-reaffirms-sell-rating-for-joy-global-inc-joy/\" target=\"_blank\">restated</a> its Sell rating on shares.</li><li>Now read <a href=\"https://seekingalpha.com/article/3956377-joy-global-buy-rally\" target=\"_blank\"><b>Joy Global: Don't Buy The Rally</b></a></li></ul><div class=\"tiny-share-widget\" data-id=\"3171727\" data-linked=\"Goldman reaffirms Sell rating on Joy\" data-tweet=\"$JOY - Goldman reaffirms Sell rating on Joy https://seekingalpha.com/news/3171727-goldman-reaffirms-sell-rating-on-joy?source=tweet\" data-url=\"https://seekingalpha.com/news/3171727-goldman-reaffirms-sell-rating-on-joy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171718\" data-ts=\"1459953829\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIND\" target=\"_blank\">BIND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171718-bind-therapeutics-to-cut-38-of-workforce-after-lead-product-candidate-fails-to-deliver-in-two\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BIND Therapeutics to cut 38% of workforce after lead product candidate fails to deliver in two mid-stage studies; shares slump 26%</a></h4><ul>\n<li>Thinly traded nano cap BIND Therapeutics (<a href=\"https://seekingalpha.com/symbol/BIND\" title=\"BIND Therapeutics, Inc.\">BIND</a> <font color=\"red\">-26.2%</font>) slumps on almost triple normal volume, albeit on turnover of only ~210K shares, in response to its announcement that it will cut 38% of its employees by the end of the month in order to reduce operating costs. It also plans to assess its options regarding its wholly owned subsidiary in Moscow.</li>\n<li>The move was prompted by a shift in R&amp;D strategy and by less-than-hoped-for results from two Phase 2 studies of lead product candidate BIND-014, an ACCURIN drug candidate containing the chemo agent docetaxel.</li>\n<li>The first trial, called <a href=\"https://clinicaltrials.gov/ct2/show/NCT02283320?term=bind-014&amp;rank=5\" target=\"_blank\">iNSITE 1</a>, evaluated BIND-014 in advanced non-small cell lung cancer. The primary endpoint was the disease control rate (DCR), which includes total responders, partial responders and those with stable disease (no progression). BIND-014 showed a 52.5% DCR at week 6 in the intent-to-treat population and 70.0% in the per-protocol population, below and above the protocol-defined threshold for success of 65.0%. The company intends to seek licensing or collaboration deals for the further development for the indication.</li>\n<li>The second, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02479178?term=bind-014&amp;rank=4\" target=\"_blank\">iNSITE 2</a>, was assessing BIND-014 in advanced cervical and head and neck cancers. In the first stage, the objective response rate was only 10% for the head and neck cohort and 0% for the cervical group. As a result, the company has stopped enrollment.</li>\n<li>The company will continue its development and collaboration activities in line with its innovative medicines strategy, specifically, transitioning the company from a technology platform business to one focused on leveraging the benefits of ACCURINS to maximize the clinical benefits for patients.</li>\n<li>\n<a href=\"http://bindtherapeutics.com/technology/accurins.html\" target=\"_blank\">ACCURINS </a>are nanoparticles that incorporate a therapeutic payload and are designed to have prolonged circulation in the bloodstream thereby providing controlled and timely release of the therapy to diseased tissue or cells.</li>\n<li>Read now <a href=\"https://seekingalpha.com/article/3006746-its-time-to-invest-in-bind-therapeutics\" target=\"_blank\">It's Time To Invest In BIND Therapeutics </a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171718\" data-linked=\"BIND Therapeutics to cut 38% of workforce after lead product candidate fails to deliver in two mid-stage studies; shares slump 26%\" data-tweet=\"$BIND - BIND Therapeutics to cut 38% of workforce after lead product candidate fails to deliver in two mid-stage studies; shares slump 26% https://seekingalpha.com/news/3171718-bind-therapeutics-to-cut-38-of-workforce-after-lead-product-candidate-fails-to-deliver-in-two?source=tweet\" data-url=\"https://seekingalpha.com/news/3171718-bind-therapeutics-to-cut-38-of-workforce-after-lead-product-candidate-fails-to-deliver-in-two\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171726\" data-ts=\"1459953771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHGE\" target=\"_blank\">BHGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171726-baker-hughes-downgraded-deutsche-bank-deal-close-coin-flip-best\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baker Hughes downgraded at Deutsche Bank, as deal close &quot;a coin flip at best&quot;</a></h4><ul>     <li>Baker Hughes (BHI <font color=\"green\">+5.3%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/04/7809425/why-deutsche-bank-is-no-longer-buying-baker-hughes\" target=\"_blank\">downgraded to Hold</a> from Buy with a $43 price target, cut from $78, at Deutsche Bank, which expects shares to remain relatively range bound during any litigation process concerning the Halliburton (<a href=\"https://seekingalpha.com/symbol/HAL\" title=\"Halliburton Company\">HAL</a> <font color=\"green\">+4.8%</font>) merger.</li>     <li>Although BHI and HAL will have a strong case to fight the <a href=\"https://www.justice.gov/opa/pr/justice-department-sues-block-halliburton-s-acquisiton-baker-hughes\" target=\"_blank\">DoJ lawsuit</a>, the odds of the merger closing are \"<a href=\"http://thefly.com/landingPageNews.php?id=2353064&amp;headline=BHI;HAL-Deutsche-says-odds-of-Baker-Hughes-deal-closing-a-coin-flip-at-best\" target=\"_blank\">a coin flip at best</a>,\" Deutsche Bank says</li>     <li>The firm lowers its 2016 EPS estimate for BHI to a $0.42 loss from its earlier outlook for a $0.37 loss, and cuts its 2017 EPS estimate to $1.20 from $1.60, citing challenges BHI would face as a stand-alone company.</li>     <li>Deutsche Bank maintains a Buy rating on HAL while lowering its price target to $40 from $53, as the company likely would be on \"extremely strong footing\u201d even if the deal falls through</li>     <li>\"If anything, the lack of distractions after well over a year of merger related activities as well as investors currently on the sidelines coming in could actually benefit [HAL] in the short-term,\u201d the firm says.</li>\n<li>Now read <a href=\"https://seekingalpha.com/news/3171717-official-doj-files-lawsuit-block-halliburton-buying-baker-hughes\" target=\"_blank\"><strong>It's official: DoJ files lawsuit to block Halliburton from buying Baker Hughes</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171726\" data-linked=\"Baker Hughes downgraded at Deutsche Bank, as deal close &quot;a coin flip at best&quot;\" data-tweet=\"$BHGE $BKR $HAL - Baker Hughes downgraded at Deutsche Bank, as deal close &quot;a coin flip at best&quot; https://seekingalpha.com/news/3171726-baker-hughes-downgraded-deutsche-bank-deal-close-coin-flip-best?source=tweet\" data-url=\"https://seekingalpha.com/news/3171726-baker-hughes-downgraded-deutsche-bank-deal-close-coin-flip-best\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171725\" data-ts=\"1459953521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPLA\" target=\"_blank\">LPLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171725-nice-bounce-for-trio-of-asset-managers-after-new-dol-rule\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nice bounce for trio of asset managers after new DOL rule</a></h4><ul>\n<li>Released today, the new fiduciary rule regarding management of retirement accounts appears to be <a href=\"https://seekingalpha.com/news/3171695-industry-concessions-d-c-rolls-new-retirement-industry-rules\" target=\"_blank\">not as \"broker-unfriendly\" as feared</a>. Among the roughed-up asset managers bouncing are LPL Financial (<a href=\"https://seekingalpha.com/symbol/LPLA\" title=\"LPL Financial Holdings Inc.\">LPLA</a> <font color=\"green\">+6.9%</font>), Waddell &amp; Reed (<a href=\"https://seekingalpha.com/symbol/WDR\" title=\"Waddell &amp; Reed Financial Inc\">WDR</a> <font color=\"green\">+6.3%</font>), and Raymond James (<a href=\"https://seekingalpha.com/symbol/RJF\" title=\"Raymond James Financial Inc.\">RJF</a> <font color=\"green\">+3%</font>).</li>\n<li>Now read:<a href=\"https://seekingalpha.com/article/3834886-lpl-financial-poised-short-squeeze\" target=\"_blank\"> LPL Financial Poised For A Short Squeeze?</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171725\" data-linked=\"Nice bounce for trio of asset managers after new DOL rule\" data-tweet=\"$LPLA $LPLA $WDR - Nice bounce for trio of asset managers after new DOL rule https://seekingalpha.com/news/3171725-nice-bounce-for-trio-of-asset-managers-after-new-dol-rule?source=tweet\" data-url=\"https://seekingalpha.com/news/3171725-nice-bounce-for-trio-of-asset-managers-after-new-dol-rule\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171717\" data-ts=\"1459951941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAL\" target=\"_blank\">HAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171717-official-doj-files-lawsuit-to-block-halliburton-from-buying-baker-hughes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">It&#39;s official: DoJ files lawsuit to block Halliburton from buying Baker Hughes</a></h4><ul>     <li>Halliburton (<a href=\"https://seekingalpha.com/symbol/HAL\" title=\"Halliburton Company\">HAL</a> <font color=\"green\">+5.2%</font>) and Baker Hughes (BHI <font color=\"green\">+5.2%</font>) move higher following official news that the U.S. Justice Department has <a href=\"https://www.justice.gov/opa/pr/justice-department-sues-block-halliburton-s-acquisiton-baker-hughes\" target=\"_blank\">filed a civil antitrust suit</a> seeking to block their $35B merger deal, confirming <a href=\"https://seekingalpha.com/news/3171557-reports-doj-file-lawsuit-stop-halliburton-baker-hughes-deal\" target=\"_blank\">earlier reports</a>.</li>     <li>The DoJ alleges the HAL-BHI merger, which would combine the no. 2 and no. 3 oil services companies, threatens to eliminate competition, raise prices and reduce innovation in the oilfield services industry.</li>     <li>The companies say they will \"vigorously contest\" the DoJ action, and that the combination would provide customers with access to high quality and more efficient products and services, and an opportunity to reduce their cost per boe.</li>\n<li>Now read <a href=\"https://seekingalpha.com/article/3963503-halliburton-valueact-really-mullet?cache=0.9651207006776029\" target=\"_blank\"><strong>Halliburton: ValueAct really is the mullet</strong></a>\n</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3171717\" data-linked=\"It&#39;s official: DoJ files lawsuit to block Halliburton from buying Baker Hughes\" data-tweet=\"$HAL $HAL $BKR - It&#39;s official: DoJ files lawsuit to block Halliburton from buying Baker Hughes https://seekingalpha.com/news/3171717-official-doj-files-lawsuit-to-block-halliburton-from-buying-baker-hughes?source=tweet\" data-url=\"https://seekingalpha.com/news/3171717-official-doj-files-lawsuit-to-block-halliburton-from-buying-baker-hughes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171714\" data-ts=\"1459951503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171714-earnings-jitters-around-bed-bath-beyond\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Earnings jitters around Bed Bath &amp; Beyond</a></h4><ul>     <li>Bed, Bath &amp; Beyond (<a href=\"https://seekingalpha.com/symbol/BBBY\" title=\"Bed Bath &amp; Beyond Inc.\">BBBY</a> <font color=\"red\">-1.2%</font>) trades weak with Q4 earnings due out after the market close today.</li>     <li>The consensus estimate from analysts is for revenue of $3.39B and EPS of $1.80 to be reported.</li>     <li>What to watch: Commentary from management on how heavy the retailer has been leaning on the promotional lever during Q1 and where it stands with inventory management could be crucial.</li>     <li>Now read <a href=\"https://seekingalpha.com/article/3963490-bed-bath-and-beyond-earnings-much-worse-can-get\" target=\"_blank\"><strong>Bed Bath &amp; Beyond Earnings: How Much Worse Can It Get?</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171714\" data-linked=\"Earnings jitters around Bed Bath &amp; Beyond\" data-tweet=\"$BBBY - Earnings jitters around Bed Bath &amp; Beyond https://seekingalpha.com/news/3171714-earnings-jitters-around-bed-bath-beyond?source=tweet\" data-url=\"https://seekingalpha.com/news/3171714-earnings-jitters-around-bed-bath-beyond\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171712\" data-ts=\"1459951174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMB\" target=\"_blank\">WMB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171712-williams-sues-energy-transfer-over-preferred-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Williams sues Energy Transfer over preferred share offering</a></h4><ul>     <li>Williams Companies (<a href=\"https://seekingalpha.com/symbol/WMB\" title=\"Williams Companies Inc\">WMB</a> <font color=\"green\">+0.5%</font>) says it is suing Energy Transfer Equity (ETE <font color=\"green\">+3.7%</font>) and Chairman Kelcy Warren to block a private preferred share offering disclosed last month, saying it was a breach of their merger agreement and provides certain ETE investors preferential treatment on its distributions.</li>     <li>ETE issued convertible units to certain investors, including Warren, last month to raise funds to help cover the $6B it will owe WMB investors when the deal closes.</li>     <li>WMB says it has commenced litigation to protect the interests of its stockholders while remaining committed to working with ETE to ensure the financial strength of the combined company.</li>     <li>ETP <font color=\"green\">+3.3%</font>, <a href=\"https://seekingalpha.com/symbol/WPZ\" title=\"Williams Partners L.P.\">WPZ</a> <font color=\"green\">+2.3%</font>.</li>     <li>Now read <a href=\"https://seekingalpha.com/news/3171274-energy-transfer-partners-cut-hold-stifel-citing-looming-challenges\" target=\"_blank\"><strong>Energy Transfer Partners cut to Hold at Stifel, citing \"looming challenges\"</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171712\" data-linked=\"Williams sues Energy Transfer over preferred share offering\" data-tweet=\"$WMB $WMB $ET - Williams sues Energy Transfer over preferred share offering https://seekingalpha.com/news/3171712-williams-sues-energy-transfer-over-preferred-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3171712-williams-sues-energy-transfer-over-preferred-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>104&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171706\" data-ts=\"1459950795\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GHL\" target=\"_blank\">GHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171706-greenhill-co-stung-goldman-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Greenhill &amp; Co. stung by Goldman downgrade</a></h4><ul><li>Goldman Sachs throws in the towel on Greenhill &amp; Co. (<a href='https://seekingalpha.com/symbol/GHL' title='Greenhill & Co., Inc.'>GHL</a> <font color='red'>-4.4%</font>) with a downgrade to Neutral from Buy.</li><li>The stock's<font color='red'> lower by 33%</font>&nbsp;YTD and&nbsp;<font color='red'>53% Y/Y</font>.</li><li>Now read:&nbsp;<a href=\"https://seekingalpha.com/article/2626855-greenhill-what-has-changed\" target=\"_blank\">Greenhill: What Has Changed?</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3171706\" data-linked=\"Greenhill &amp; Co. stung by Goldman downgrade\" data-tweet=\"$GHL - Greenhill &amp; Co. stung by Goldman downgrade https://seekingalpha.com/news/3171706-greenhill-co-stung-goldman-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3171706-greenhill-co-stung-goldman-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171704\" data-ts=\"1459950536\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEIC\" target=\"_blank\">SEIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171704-sei-investments-boosted-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SEI Investments boosted by upgrade</a></h4><ul>\n<li>KBW pulls its Underperform rating on SEI Investments (<a href=\"https://seekingalpha.com/symbol/SEIC\" title=\"SEI Investments Company\">SEIC</a> <font color=\"green\">+2.5%</font>), and upgrades <a href=\"http://www.streetinsider.com/Analyst+PT+Change/Keefe%2C+Bruyette+%26+Woods+Upgrades+SEI+Investments+%28SEIC%29+to+Market+Perform/11479524.html\" target=\"_blank\">to Market Perform</a>. The new price target of $45 is up from $38, and compares to the current level of $43.55.</li>\n<li>The stock's <font color=\"red\">lower by 17%</font> YTD.</li>\n<li>Now read: <a href=\"https://seekingalpha.com/article/3574536-sei-investments-company-stock-watch\" target=\"_blank\">SEI Investments Company: A Stock To Watch</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171704\" data-linked=\"SEI Investments boosted by upgrade\" data-tweet=\"$SEIC - SEI Investments boosted by upgrade https://seekingalpha.com/news/3171704-sei-investments-boosted-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3171704-sei-investments-boosted-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171692\" data-ts=\"1459948547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171692-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> FHCO <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/MOMO' title='Momo'>MOMO</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='green'>+7%</font>. CJES <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CREE' title='Cree, Inc.'>CREE</a> <font color='red'>-18%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3171692\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$VERU $MOMO $SRPT - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3171692-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3171692-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171691\" data-ts=\"1459948513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171691-gogoplus-3_2-on-deal-to-retrofit-airbus-jets-new-in-flight-tech\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gogo +3.2% on deal to retrofit Airbus jets with new in-flight tech</a></h4><ul>   <li>Gogo (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GOGO\" title=\"Gogo\">GOGO</a>) is <font color=\"green\">up 3.2%</font> premarket as it announces a partnership with the Airbus Corporate Jet Centre (<a href=\"https://seekingalpha.com/symbol/EADSY\" title=\"Airbus SE ADR\">OTCPK:EADSY</a>) that will put its 2Ku connectivity technology on new Airbus A350s.</li>    <li>The move allows for retrofit installation of new-generation antennas for A350s via a factory-authorized installation. Previously only first-generation gimbaled antennas went on the planes.</li>    <li>Delta Air Lines will be first to take advantage of the new arrangement and first to bring domestic 2Ku connectivity, when it takes delivery of such an A350 in 2017.</li>    <li>Now read <a href=\"https://seekingalpha.com/article/3901056-lawsuit-american-airlines-scare-tactic\" target=\"_blank\"><b>The Lawsuit From American Airlines Is A Scare Tactic »</b></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171691\" data-linked=\"Gogo +3.2% on deal to retrofit Airbus jets with new in-flight tech\" data-tweet=\"$GOGO $GOGO $EADSY - Gogo +3.2% on deal to retrofit Airbus jets with new in-flight tech https://seekingalpha.com/news/3171691-gogoplus-3_2-on-deal-to-retrofit-airbus-jets-new-in-flight-tech?source=tweet\" data-url=\"https://seekingalpha.com/news/3171691-gogoplus-3_2-on-deal-to-retrofit-airbus-jets-new-in-flight-tech\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171682\" data-ts=\"1459947518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MON\" target=\"_blank\">MON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171682-monsanto-indicates-lower-fq2-results-miss-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monsanto indicates lower as FQ2 results miss expectations</a></h4><ul>     <li>Monsanto (NYSE:<a href=\"https://seekingalpha.com/symbol/MON\" title=\"Monsanto Company\">MON</a>) <font color=\"red\">-1.6%</font> premarket after reporting weaker than expected <a href=\"https://seekingalpha.com/news/3171662-monsanto-misses-0_02-misses-revenue\" target=\"_blank\">FQ2 earnings</a> and revenues, <a href=\"http://www.reuters.com/article/us-monsanto-results-idUSKCN0X31G9\" target=\"_blank\">hurt by steep discounting on its seeds and a stronger dollar</a>.</li>     <li>MON says revenue from seeds and genomics, its biggest business, fell 8.6% Y/Y in the quarter as sales of most seed types fell, while revenues in its agricultural productivity segment tumbled 30% to $715M; total sales fell 12.8% to $4.53B from $5.2B a year earlier.</li>     <li>MON reiterates its full-year EPS forecast of $4.40-$5.10, which was lowered <a href=\"https://seekingalpha.com/news/3156146-monsanto-minus-5-percent-cutting-earnings-outlook\" target=\"_blank\">last month</a> from a prior outlook for $5.10-$5.60.</li>     <li>MON says it continues to expect relatively flat Y/Y growth in gross profit from its core seeds and genomics segment in FY 2016; excluding currency headwinds of nearly $400M, MON estimates seeds and genomics gross profit to rise by single digits, driven primarily by the expected increase in potential licensing deals,  increased Intacta RR2 PRO soybean adoption and global corn market expansion.</li>     <li>Now read <a href=\"https://seekingalpha.com/article/3960120-monsantos-plan-b-buy-bayer-cropscience\" target=\"_blank\"><strong>Monsanto's Plan B: Buy Bayer Cropscience?</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171682\" data-linked=\"Monsanto indicates lower as FQ2 results miss expectations\" data-tweet=\"$MON - Monsanto indicates lower as FQ2 results miss expectations https://seekingalpha.com/news/3171682-monsanto-indicates-lower-fq2-results-miss-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3171682-monsanto-indicates-lower-fq2-results-miss-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171680\" data-ts=\"1459946913\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMI\" target=\"_blank\">CMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171680-buckingham-lowers-cummins-to-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buckingham lowers Cummins to Neutral</a></h4><ul>\n<li>Cummins (NYSE:<a href=\"https://seekingalpha.com/symbol/CMI\" title=\"Cummins Inc.\">CMI</a>) <font color=\"red\">-1.1%</font> premarket after getting hit with a <a href=\"http://www.benzinga.com/news/16/04/7808977/buckingham-research-downgrades-cummins-to-neutral\" target=\"_blank\">downgrade</a> at Buckingham.</li>\n<li>The firm lowered its rating on the stock from Buy to Neutral.</li>\n<li>Now read <a href=\"https://seekingalpha.com/article/3961144-want-cummins-might-want-wait\" target=\"_blank\"><strong>Want More Cummins? Might Want To Wait</strong></a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171680\" data-linked=\"Buckingham lowers Cummins to Neutral\" data-tweet=\"$CMI - Buckingham lowers Cummins to Neutral https://seekingalpha.com/news/3171680-buckingham-lowers-cummins-to-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3171680-buckingham-lowers-cummins-to-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171679\" data-ts=\"1459946821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171679-oppenheimer-bullish-on-sarepta-raises-price-target-to-street-high-60-shares-up-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer bullish on Sarepta, raises price target to Street-high $60; shares up 7% premarket</a></h4><ul>\n<li>Counting on FDA approval of Duchenne muscular dystrophy candidate eteplirsen, Oppenheimer raises its price target for Sarepta Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a>) to $60 (207% upside) from $45, the highest target on the Street.</li>\n<li>The Ad Comm review is scheduled for Monday, April 25. The FDA's action date (PDUFA) is May 26.</li>\n<li>SRPT is up <font color=\"green\">7%</font> premarket on increased volume.</li>\n<li>Read now <a href=\"https://seekingalpha.com/article/3963208-sarepta-rally-around-catalysts\" target=\"_blank\">Sarepta: Rally Around Catalysts</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171679\" data-linked=\"Oppenheimer bullish on Sarepta, raises price target to Street-high $60; shares up 7% premarket\" data-tweet=\"$SRPT - Oppenheimer bullish on Sarepta, raises price target to Street-high $60; shares up 7% premarket https://seekingalpha.com/news/3171679-oppenheimer-bullish-on-sarepta-raises-price-target-to-street-high-60-shares-up-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3171679-oppenheimer-bullish-on-sarepta-raises-price-target-to-street-high-60-shares-up-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171672\" data-ts=\"1459945452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNGA\" target=\"_blank\">MNGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171672-magnegas-moves-new-headquarters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MagneGas moves into new headquarters</a></h4><ul>\n<li>MagneGas (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MNGA\" title=\"MagneGas Corporation\">MNGA</a>) has moved into its new 18K sq. ft. company headquarters, located within an industrial area outside of Tampa, Florida.</li>\n<li>The facility is within closer proximity to existing/potential customers and within easy access to major highways.</li>\n<li>In other news: The company has expanded MagneGas2 production by over 200%.</li>\n<li>MNGA <font color=\"green\">+3.9%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171672\" data-linked=\"MagneGas moves into new headquarters\" data-tweet=\"$MNGA $TRNX - MagneGas moves into new headquarters https://seekingalpha.com/news/3171672-magnegas-moves-new-headquarters?source=tweet\" data-url=\"https://seekingalpha.com/news/3171672-magnegas-moves-new-headquarters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171671\" data-ts=\"1459945423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOC\" target=\"_blank\">DOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171671-physicians-realty-trust-upsizes-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Physicians Realty Trust upsizes capital raise</a></h4><ul>\n<li>The company sold 22.5M shares at a price of $17.85 each vs. the originally planned sale of 18M shares. Gross proceeds were $387.9M, and the underwriters have an option to buy another 3.375M shares at that price.</li>\n<li>The funds are to be used to help pay for the <a href=\"https://seekingalpha.com/news/3171580-physicians-realty-trust-makes-huge-purchase\" target=\"_blank\">Catholic Health Initiatives acquisition</a>.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/DOC\" title=\"Physicians Realty Trust\">DOC</a> -1.35% premarket to $18.21.</li>\n<li>Now read: <a href=\"https://seekingalpha.com/article/3896856-physicians-realty-healthy-ingredients-sleep-well-night\" target=\"_blank\">Physicians Realty Has All The Healthy Ingredients To Sleep Well At Night</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171671\" data-linked=\"Physicians Realty Trust upsizes capital raise\" data-tweet=\"$DOC - Physicians Realty Trust upsizes capital raise https://seekingalpha.com/news/3171671-physicians-realty-trust-upsizes-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3171671-physicians-realty-trust-upsizes-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171668\" data-ts=\"1459944924\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171668-constellation-brands-reports-fq4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Constellation Brands reports FQ4 results</a></h4><ul>\n<li>Constellation Brands (NYSE:<a href=\"https://seekingalpha.com/symbol/STZ\" title=\"Constellation Brands, Inc.\">STZ</a>): FQ4 EPS of $1.19</li>\n<li>Revenue of $1.54B (+14.1% Y/Y)</li>\n<li>Shares <font color=\"green\">+2.88%</font> PM.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171668\" data-linked=\"Constellation Brands reports FQ4 results\" data-tweet=\"$STZ - Constellation Brands reports FQ4 results https://seekingalpha.com/news/3171668-constellation-brands-reports-fq4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3171668-constellation-brands-reports-fq4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171665\" data-ts=\"1459944553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROAN\" target=\"_blank\">ROAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171665-linn-energy-in-settlement-deal-creditors-eyes-potential-chapter-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Linn Energy in settlement deal with some creditors, eyes potential Chapter 11</a></h4><ul>     <li>Linn Energy (LINE) says it entered into a settlement agreement with some of its debtholders about potential restructuring that could  include  Chapter 11 bankruptcy.</li>     <li>Linn says the agreement was with creditors who hold two-thirds of its $1B outstanding senior secured second-lien notes due 2020, and that it is no longer in technical default over mortgages associated with the notes.</li>     <li>LINE <font color=\"red\">-2.5%</font>, LNCO <font color=\"green\">+3.2%</font> premarket.</li>     <li>Now read <a href=\"https://seekingalpha.com/article/3963436-linn-energy-default-now\" target=\"_blank\"><strong>Linn Energy is out of default... for now</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171665\" data-linked=\"Linn Energy in settlement deal with some creditors, eyes potential Chapter 11\" data-tweet=\"$ROAN - Linn Energy in settlement deal with some creditors, eyes potential Chapter 11 https://seekingalpha.com/news/3171665-linn-energy-in-settlement-deal-creditors-eyes-potential-chapter-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3171665-linn-energy-in-settlement-deal-creditors-eyes-potential-chapter-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171646\" data-ts=\"1459942340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTA\" target=\"_blank\">HTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171646-healthcare-trust-of-america-lower-after-pricing-secondary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare Trust of America lower after pricing secondary</a></h4><ul>\n<li>The company sold 5.2M shares at a price of $28.90 each for roughly $150M of gross proceeds. The underwriters have an option to buy up to another 780K shares at that price.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/HTA\" title=\"Healthcare Trust of America, Inc.\">HTA</a> <font color=\"red\">-2.5%</font> premarket to $28.79.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3171583-healthcare-trust-america-raising-capital\" target=\"_blank\">Healthcare Trust of America raising capital</a> (April 5)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171646\" data-linked=\"Healthcare Trust of America lower after pricing secondary\" data-tweet=\"$HTA - Healthcare Trust of America lower after pricing secondary https://seekingalpha.com/news/3171646-healthcare-trust-of-america-lower-after-pricing-secondary?source=tweet\" data-url=\"https://seekingalpha.com/news/3171646-healthcare-trust-of-america-lower-after-pricing-secondary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171644\" data-ts=\"1459941991\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFE\" target=\"_blank\">PFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171644-allergan-pfizer-merger-officially-off-pfizer-to-reimburse-allergan-150m-for-expenses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allergan/Pfizer merger officially off; Pfizer to reimburse Allergan $150M for expenses</a></h4><ul>\n<li>Although disheartened that its merger with Pfizer (NYSE:<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a>) is dead, Allergan (NYSE:<a href=\"https://seekingalpha.com/symbol/AGN\" title=\"Allergan plc\">AGN</a>) is bullish on its standalone profile. CEO Brent Saunders says, \"While we are disappointed that the Pfizer transaction will no longer mover forward, Allergan is poised to deliver strong, sustainable growth built of a set of powerful attributes. Our pipeline is one of the strongest in the industry, loaded with 70 mid-to-late-stage programs including 14 expected approvals and 16 regulatory submissions in 2016 alone.\"</li>\n<li>Based on a preliminary review of the proposed regulations from the U.S. Treasury Department, the company believes they will not have a material impact on its standalone tax rate. Q1 earnings will be reported no later than May 10. During the conference call, management will update investors on its plans to simplify the company's operations after it divests its generics business to (NYSE:<a href=\"https://seekingalpha.com/symbol/TEVA\" title=\"Teva Pharmaceutical Industries Limited\">TEVA</a>).</li>\n<li>Allergan will host a brief conference call this morning at 10:00 am ET to discuss its standalone prospects.</li>\n<li>Pfizer says it will make a decision on splitting the company's innovative and established businesses by the end of the year. It will report Q1 results on May 3. It has agreed to reimburse Allergan $150M for merger-related expenses.</li>\n<li>PFE is up <font color=\"green\">1%</font> and AGN is down <font color=\"red\">1%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171644\" data-linked=\"Allergan/Pfizer merger officially off; Pfizer to reimburse Allergan $150M for expenses\" data-tweet=\"$PFE $PFE $AGN - Allergan/Pfizer merger officially off; Pfizer to reimburse Allergan $150M for expenses https://seekingalpha.com/news/3171644-allergan-pfizer-merger-officially-off-pfizer-to-reimburse-allergan-150m-for-expenses?source=tweet\" data-url=\"https://seekingalpha.com/news/3171644-allergan-pfizer-merger-officially-off-pfizer-to-reimburse-allergan-150m-for-expenses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171642\" data-ts=\"1459941922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPN\" target=\"_blank\">GPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171642-on-global-payments-fq3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Global Payments&#39; FQ3</a></h4><ul>     <li>Global Payments (NYSE:<a href=\"https://seekingalpha.com/symbol/GPN\" title=\"Global Payments Inc.\">GPN</a>) reports adjusted revenue rose 11% on a constant currency basis in FQ3.</li>     <li>Segment Adjusted revenue : North America: $311.62M (+6.2%); Europe: $130.47M (+8%); Asia-Pacific: $54.88M (+2.5%).</li>     <li>Segment Cash earnings : North America: $84.84M (+9.1%); Europe: $64.90M (+8.2%); Asia-Pacific: $17.79M (+28.6%).</li>     <li>Cash operating margin grew 50 bps to 28.7%.</li>     <li>\n<b>FY2016 Guidance</b>: Adjusted total revenue: $2.06B to $2.10B (+6% to +8%); GAAP revenue: $2.87B to $2.95B (+4% to +6%); Cash EPS: $2.93 to $3 (+16% to 19%); GAAP diluted EPS: $2.36 to $2.43 (+14% to +18%).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3171642\" data-linked=\"More on Global Payments&#39; FQ3\" data-tweet=\"$GPN - More on Global Payments&#39; FQ3 https://seekingalpha.com/news/3171642-on-global-payments-fq3?source=tweet\" data-url=\"https://seekingalpha.com/news/3171642-on-global-payments-fq3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3171633\" data-ts=\"1459940182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSM\" target=\"_blank\">MSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3171633-on-msc-industrial-directs-fq2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on MSC Industrial Direct&#39;s FQ2</a></h4><ul>\n<li>MSC Industrial Direct (NYSE:<a href=\"https://seekingalpha.com/symbol/MSM\" title=\"MSC Industrial Direct Co. Inc.\">MSM</a>) reports gross margin rate declined 30 bps to 45.1%</li>\n<li>Adjusted operating margin rate fell 40 bps to 11.8%.</li>\n<li>FQ3 Guidance: Net sales: $729M to $741M; Average daily sales growth: roughly -3% Y/Y; Diluted EPS: $0.98 to $1.02.</li>\n<li>FQ2 results</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3171633\" data-linked=\"More on MSC Industrial Direct&#39;s FQ2\" data-tweet=\"$MSM - More on MSC Industrial Direct&#39;s FQ2 https://seekingalpha.com/news/3171633-on-msc-industrial-directs-fq2?source=tweet\" data-url=\"https://seekingalpha.com/news/3171633-on-msc-industrial-directs-fq2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:56 AM </div></div></li>","count":45,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}